India Statin Market Size, Share, Trends and Forecast by Type, Therapeutic Area, Drug Class, Application, Distribution, and Region, 2026-2034

Description

The India statin market size reached USD 534.3 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 676.6 Million by 2034, exhibiting a growth rate (CAGR) of 2.66% during 2026-2034. The India statin market is expanding due to the increasing prevalence of cardiovascular diseases, growing adoption of generic drugs, and government initiatives promoting affordable treatments. Rising healthcare awareness, improved accessibility through digital pharmacies, and advancements in sustained-release formulations are further driving market growth.

India Statin Market Trends:

Growing Prevalence of Heart Diseases Driving Statin Demand

The rising prevalence of heart diseases in India is significantly influencing the demand for cholesterol-lowering medications like statins. Heart disease, including conditions such as coronary artery disease and stroke, remains a major cause of mortality in India, particularly in urban areas where lifestyle changes and dietary habits are contributing to increased cholesterol levels. The growing number of individuals affected by these conditions has created a strong need for effective treatments to manage dyslipidemia and reduce associated cardiovascular risks. In July 2024, the Cardiological Society of India (CSI) addressed this growing concern by releasing the country's first-ever guidelines for managing high cholesterol. The guidelines focus on the importance of maintaining proper LDL (bad cholesterol) and HDL (good cholesterol) levels, which directly ties into the management of heart diseases. The guidelines underscore statins as the primary treatment for dyslipidemia, recommending their use as the first line of defense against high cholesterol. This targeted approach is expected to drive significant demand for statins, as these medications have long been established as an effective method for reducing LDL cholesterol and lowering the risk of heart diseases. As the guidelines are adopted, healthcare providers will be more likely to prescribe statins, accelerating their presence in the Indian market and contributing to a growing need for cholesterol management solutions.

Rising Awareness of Cholesterol Management Alternatives

As awareness about high cholesterol and its associated health risks rises, new treatment options are gaining attention. Inclisiran, a novel cholesterol-lowering injection, is a key player in this shift. Expected to debut in India in January 2024, inclisiran presents an alternative to statins, particularly for patients who are intolerant to statins or have not responded well to them. The introduction of this drug will significantly expand the treatment landscape for high cholesterol, offering physicians a new tool to manage patients with complex cases. This increased awareness of available treatment alternatives will likely stimulate interest in cholesterol management, driving further adoption of both statins and newer therapies like inclisiran. Statins remain the primary treatment for high cholesterol in India, but inclisiran's introduction will lead to a more nuanced approach to managing cholesterol, allowing patients who face side effects with statins to find relief with this new option. This growing recognition of cholesterol management, coupled with the introduction of inclisiran, will likely drive a shift in the Indian statin market. As more patients become aware of cholesterol's dangers and seek solutions, demand for cholesterol-lowering treatments will rise, benefiting not only statins but also the broader category of lipid-lowering therapies, including newer innovations like inclisiran. This trend towards expanding treatment options will likely impact both the statin market and the overall heart disease market in India.

India Statin Market Segmentation:

Type Insights:

Synthetic Statins
Natural Statins

Therapeutic Area Insights:

Cardiovascular Disorders
Obesity
Inflammatory Disorders
Others

Drug Class Insights:

Atorvastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others

Application Insights:

Dyslipidemia
Others

Distribution Insights:

Hospitals
Clinics

Region Insights:

North India
South India
East India
West India
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the India statin market performed so far and how will it perform in the coming years?
What is the breakup of the India statin market on the basis of type?
What is the breakup of the India statin market on the basis of lease type?
What is the breakup of the India statin market on the basis of service provider type?
What is the breakup of the India statin market on the basis of tenure?
What are the various stages in the value chain of the India statin market?
What are the key driving factors and challenges in the India statin?
What is the structure of the India statin market and who are the key players?
What is the degree of competition in the India statin market?

Product Code: SR112026A29689

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 India Statin Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 India Statin Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 India Statin Market - Breakup by Type

6.1 Synthetic Statins
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Natural Statins
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)

7 India Statin Market - Breakup by Therapeutic Area

7.1 Cardiovascular Disorders
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Obesity
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Inflammatory Disorders
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Others
- 7.4.1 Historical and Current Market Trends (2020-2025)
- 7.4.2 Market Forecast (2026-2034)

8 India Statin Market - Breakup by Drug Class

8.1 Atorvastatin
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Fluvastatin
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Lovastatin
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)
8.4 Pravastatin
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Forecast (2026-2034)
8.5 Simvastatin
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Forecast (2026-2034)
8.6 Others
- 8.6.1 Historical and Current Market Trends (2020-2025)
- 8.6.2 Market Forecast (2026-2034)

9 India Statin Market - Breakup by Application

9.1 Dyslipidemia
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Others
- 9.2.1 Historical and Current Market Trends (2020-2025)
- 9.2.2 Market Forecast (2026-2034)

10 India Statin Market - Breakup by Distribution

10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Forecast (2026-2034)
10.2 Clinics
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Forecast (2026-2034)

11 India Statin Market - Breakup by Region

11.1 North India
- 11.1.1 Overview
- 11.1.2 Historical and Current Market Trends (2020-2025)
- 11.1.3 Market Breakup by Type
- 11.1.4 Market Breakup by Therapeutic Area
- 11.1.5 Market Breakup by Drug Class
- 11.1.6 Market Breakup by Application
- 11.1.7 Market Breakup by Distribution
- 11.1.8 Key Players
- 11.1.9 Market Forecast (2026-2034)
11.2 South India
- 11.2.1 Overview
- 11.2.2 Historical and Current Market Trends (2020-2025)
- 11.2.3 Market Breakup by Type
- 11.2.4 Market Breakup by Therapeutic Area
- 11.2.5 Market Breakup by Drug Class
- 11.2.6 Market Breakup by Application
- 11.2.7 Market Breakup by Distribution
- 11.2.8 Key Players
- 11.2.9 Market Forecast (2026-2034)
11.3 East India
- 11.3.1 Overview
- 11.3.2 Historical and Current Market Trends (2020-2025)
- 11.3.3 Market Breakup by Type
- 11.3.4 Market Breakup by Therapeutic Area
- 11.3.5 Market Breakup by Drug Class
- 11.3.6 Market Breakup by Application
- 11.3.7 Market Breakup by Distribution
- 11.3.8 Key Players
- 11.3.9 Market Forecast (2026-2034)
11.4 West India
- 11.4.1 Overview
- 11.4.2 Historical and Current Market Trends (2020-2025)
- 11.4.3 Market Breakup by Type
- 11.4.4 Market Breakup by Therapeutic Area
- 11.4.5 Market Breakup by Drug Class
- 11.4.6 Market Breakup by Application
- 11.4.7 Market Breakup by Distribution
- 11.4.8 Key Players
- 11.4.9 Market Forecast (2026-2034)

12 India Statin Market - Competitive Landscape

12.1 Overview
12.2 Market Structure
12.3 Market Player Positioning
12.4 Top Winning Strategies
12.5 Competitive Dashboard
12.6 Company Evaluation Quadrant

13 Profiles of Key Players

13.1 Company A
- 13.1.1 Business Overview
- 13.1.2 Products Offered
- 13.1.3 Business Strategies
- 13.1.4 SWOT Analysis
- 13.1.5 Major News and Events
13.2 Company B
- 13.2.1 Business Overview
- 13.2.2 Products Offered
- 13.2.3 Business Strategies
- 13.2.4 SWOT Analysis
- 13.2.5 Major News and Events
13.3 Company C
- 13.3.1 Business Overview
- 13.3.2 Products Offered
- 13.3.3 Business Strategies
- 13.3.4 SWOT Analysis
- 13.3.5 Major News and Events
13.4 Company D
- 13.4.1 Business Overview
- 13.4.2 Products Offered
- 13.4.3 Business Strategies
- 13.4.4 SWOT Analysis
- 13.4.5 Major News and Events
13.5 Company E
- 13.5.1 Business Overview
- 13.5.2 Products Offered
- 13.5.3 Business Strategies
- 13.5.4 SWOT Analysis
- 13.5.5 Major News and Events

14 India Statin Market - Industry Analysis

14.1 Drivers, Restraints, and Opportunities
- 14.1.1 Overview
- 14.1.2 Drivers
- 14.1.3 Restraints
- 14.1.4 Opportunities
14.2 Porters Five Forces Analysis
- 14.2.1 Overview
- 14.2.2 Bargaining Power of Buyers
- 14.2.3 Bargaining Power of Suppliers
- 14.2.4 Degree of Competition
- 14.2.5 Threat of New Entrants
- 14.2.6 Threat of Substitutes
14.3 Value Chain Analysis